Measuring onset of antidepressant action in clinical trials: An overview of definitions and methodology

Journal of Clinical Psychiatry

Volumn 62, Issue SUPPL. 4, 2001, Pages 12-16

  Leon, A C ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; IMIPRAMINE; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG RESEARCH; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MEASUREMENT; METHODOLOGY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; CLINICAL PROTOCOLS; CLINICAL TRIALS; DEPRESSIVE DISORDER; HUMANS; PERSONALITY INVENTORY; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; STATISTICS; SURVIVAL ANALYSIS; TERMINOLOGY; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035114290     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. The definition and operational criteria for treatment outcome of major depressive disorder: A review of the current research literature
2. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Remission, recovery, relapse, and recurrence
3. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition
4. The functioning and well-being of depressed patients: Results from the Medical Outcomes Study
5. Service utilization and social morbidity associated with depressive symptoms in the community
6. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders
7. A rating scale for depression
8. An inventory for measuring depression
9. A new depression scale designed to be sensitive to change
10. Coefficient alpha and the internal structure of tests
11. More reliable outcome measures can reduce sample size requirements
12. Clinical trials in psychiatry: Should protocol deviation censor patient data?
13. Application of random-effects pattern-mixture models for missing data in longitudinal studies
14. Some conceptual and statistical issues in analysis of longitudinal psychiatric data: Application to the NIMH Treatment of Depression Collaborative Research Program dataset
15. Random-effects models for longitudinal data
16. A random-effects ordinal regression model for multilevel analysis
17. Tutorial on modeling ordered categorical response data
18. A regulatory perspective on pharmacokinetic/pharmacodynamic modeling
19. Onset and duration: Measurement and analysis
20. Meptazinol and morphine in postoperative pain assessed with a new method for onset and duration
21. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo
22. Treating the depression associated with panic disorder